NOP16 polyclonal (C-term), anti-human
€0.00
In stock
SKU
AC-AP18919b
Catalog Number: AC-AP18919b
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB30512
Applications: WB
Datasheet
Request Information
Size: 80 µl, 400 µl
Isotype: Rabbit IgG
Clone Name: RB30512
Applications: WB
Datasheet
Request Information
Background:
NOP16 is transcriptionally regulated by c-Myc (MYC; MIM190080), upregulated in breast cancer, and overexpression isassociated with poor patient survival (Butt et al., 2008).[suppliedby OMIM].
Other Names:
Nucleolar protein 16, HBV pre-S2 trans-regulated protein 3, NOP16
Target/Specificity:
This NOP16 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 129-158 amino acids from the C-terminal region of human NOP16.
Antigen Region:
129-158
Antigen Type: Synthetic Peptide
Gene Name: NOP16
Gene ID: 51491
Primary Accession: Q9Y3C1
NCBI Accession: NP_001243468.1;NP_001243469.1;NP_057475.2
Other Accession: NP_057475.2
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
NOP16 is transcriptionally regulated by c-Myc (MYC; MIM190080), upregulated in breast cancer, and overexpression isassociated with poor patient survival (Butt et al., 2008).[suppliedby OMIM].
Other Names:
Nucleolar protein 16, HBV pre-S2 trans-regulated protein 3, NOP16
Target/Specificity:
This NOP16 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 129-158 amino acids from the C-terminal region of human NOP16.
Antigen Region:
129-158
Antigen Type: Synthetic Peptide
Gene Name: NOP16
Gene ID: 51491
Primary Accession: Q9Y3C1
NCBI Accession: NP_001243468.1;NP_001243469.1;NP_057475.2
Other Accession: NP_057475.2
Format: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
| Is Featured? | No |
|---|
Write Your Own Review